Vertex Pharmaceuticals, Inc’s recently made public that its Officer ALTSHULER DAVID acquired Company’s shares for reported $22084.0 on May 15 ’25. In the deal valued at $424.69 per share,52 shares were bought.
Then, Bhatia Sangeeta N. sold 400 shares, generating $202,344 in total proceeds. Upon selling the shares at $505.86, the Director now owns 4,831 shares.
Before that, Bhatia Sangeeta N. bought 400 shares. Vertex Pharmaceuticals, Inc shares valued at $202,344 were divested by the Director at a price of $505.86 per share.
Wolfe Research downgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to a Peer perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who decreased its forecast for the stock in early May from “an Outperform” to “a Market perform”. Canaccord Genuity revised its rating on February 12, 2025. It rated VRTX as “a Hold” which previously was an “a Sell”.
Price Performance Review of VRTX
On Friday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock jump 0.98% to $438.65. Over the last five days, the stock has gained 3.21%. Vertex Pharmaceuticals, Inc shares have risen nearly 8.93% since the year began. Nevertheless, the stocks have risen 2.35% over the past one year. While a 52-week high of $519.88 was reached on 03/14/25, a 52-week low of $377.85 was recorded on 01/13/25. SMA at 50 days reached $483.63, while 200 days put it at $468.87.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 432.74, which if violated will result in even more drops to 426.84. On the upside, there is a resistance level at 441.75. A further resistance level may holdings at 444.86. The Relative Strength Index (RSI) on the 14-day chart is 39.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -27.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.58%. Stochastics %K at 15.71% indicates the stock is a buying.
